Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: Novo Nordisk Links With Flagship To Create Cardiometabolic, Rare Disease Portfolio

May 12 2022

• By Joseph Haas

Deal Watch 2021 — • Source: Shutterstock

Related Content

Finance Watch: Days Of Reckoning As Biopharma Valuations, Fundraising Opportunities Fluctuate

Feb 05 2022

Deal Watch, Licensing Focus: Roche, Sanofi Exit Ongoing Anticalin Development Efforts With Pieris

Aug 16 2018

Quick Listen: Scrip’s Five Must-Know Things

Nov 01 2021

AstraZeneca Rejigs Respiratory Franchise With Fresh Covis Deal

Nov 01 2021

Well-Funded Chinese Venture Races To Clinic Amid Reviving CNS Interest

Nov 02 2021

Aptose Picks Up Hanmi’s MKI To Buoy Hematological Cancer Pipeline

Nov 05 2021

Takeda Stresses Orexin Commitment Despite Setback

Nov 02 2021

Byondis Seeks Partner For Lead ADC To Enter Crowded Breast Cancer Market

Jun 09 2021

Deal Watch: Gain To Test Enzyme-Enhancement Tech In Cancer With Zentalis

Apr 21 2021

Bone Has Tough Path Forward After Phase III Knee Osteoarthritis Fail

Aug 30 2021

Bone Therapeutics More Interested In A Partner Than A Buyer

Sep 08 2021

Evotec CSO: BMS Opt In On CNS Compound ‘Augurs Well’ For Discovery Pact

Sep 06 2021

Brickell’s Phase III Data Sets Up NDA Filing In Axillary Hyperhidrosis

Oct 07 2021

Cortexyme Alzheimer’s Study Fails; Drug Slows Cognitive Decline In Some Patients

Oct 26 2021

Europe's Biotechs In Battle For Survival

Mar 30 2022

BridgeBio, BMS Set Sail In Expanded SHP2 Collaboration

May 12 2022

Beckley Psytech Takes On Rare Disease With Psychedelics

May 12 2022

Pfizer To Put Big Marketing Muscle Behind Migraine With Biohaven Purchase

May 10 2022

Ups And Downs In Protein Degraders: Big Deals For BMS, Merck KGaA, Safety Worries For Kymera

May 05 2022

Intercept Offloads Ex-US Business To Advanz, May Be Doubling Down On NASH In US

May 05 2022

Deerfield And Illumina Join Forces To Fund New Discoveries, New Companies

May 06 2022

Moderna Teases M&A Interest As Pandemic Expected To Wind Down

May 04 2022

Rallybio Looks To Deals To Grow ‘Transformative’ Rare Disease Pipeline

Mar 02 2022

Evotec Adds To Spate Of Metabolic Deals With Lilly Collaboration

Jan 18 2022

BioMotiv: An Rx For Asset Financing Without The Venture Headache

Jun 14 2013

Celgene Joins Evotec In Its First Neurodegenerative Drug Discovery Effort

Dec 20 2016

Related Companies

Novo Nordisk A/S

Moderna, Inc.

BioSenic SA

Medsenic

Hybrigenics Pharma

Bristol Myers Squibb Company

Evotec SE

Celgene Corporation

Pfizer Inc.

Eli Lilly and Company

Takeda Pharmaceutical Co. Ltd.

Bayer AG

Sanofi

Johnson & Johnson

Roche Holding AG

Rallybio Corp.

Alexion Pharma Limited

Quince Therapeutics, Inc.

Genesis Therapeutics, Inc.

Botanix Pharmaceuticals Limited

Beckley Psytech Limited

Janssen Pharmaceuticals Inc.

Bavarian Nordic A/S

Additional Topics

Business Strategies Deals M & A Commercial Deal Watch BioPharmaceutical

More from Deal Watch

More from Deals

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window